Managers / Q3 2021 · view latest →
PFM Health Sciences, LP
CIK 0001442756 · 50 CALIFORNIA STREET, SUITE 2650, SAN FRANCISCO, CA, 94111 · 415-281-1000
Reported Value
$3.4B
Q3 2021
Positions
85
Filings on Record
31
2019–present window
Filed
Nov 15, 2021
original filing
Summary
Pfm Health Sciences, Lp reported $3.4B in U.S.-listed holdings across 85 positions for Q3 2021.
Its largest position, Horizon Therapeutics Pub L, represents 5.0% of the portfolio.
Compared with Q2 2021, the fund opened 22 new positions and exited 17.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
Composition data arrives with ticker enrichment.
Quarter-over-Quarter Changes full breakdown →
Holdings — Q3 2021
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $1.1B | 83 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $1.0B | 78 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $1.3B | 72 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $1.2B | 57 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $1.4B | 66 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $1.6B | 83 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $1.8B | 75 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $2.0B | 78 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $2.1B | 87 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $1.7B | 65 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $2.1B | 73 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $2.6B | 83 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $2.3B | 78 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $2.79T | 89 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $2.8B | 85 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $2.6B | 80 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $2.7B | 68 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $2.9B | 71 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $3.4B | 85 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $3.2B | 84 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $3.3B | 86 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $2.8B | 85 | Feb 19, 2021 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2020 | $2.2B | 77 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $1.9B | 76 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $1.2B | 61 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $2.1B | 61 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $3.4B | 72 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $5.3B | 85 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $4.5B | 90 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $3.8B | 94 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.